Compugen Insider Trades
NASDAQ: CGENHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 12 · $126.29K
- Shares bought / sold
- 0 / 51.00K
- Net activity
- Net selling $126,291
Compugen insider activity
Over the last 12 months, Compugen insiders reported 37 transactions on SEC Form 4: 0 open-market purchases and 12 sales. Insiders bought $0 and sold $126,291 worth of stock, for net insider selling of $126,291. The largest seller was Levine Zurit, with $83,357 in reported sales.
The most recent filing shows Levine Zurit (SVP, Business Development) reporting a transaction in 18,000 shares on Jul 29, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CGEN's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CGEN insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 29, 2026 | Mahler MichelleChief Medical Officer | Award | 13,500 | — | Form 4 |
| Jul 29, 2026 | ZWEIFACH SANFORD SDirector | Award | 7,500 | — | Form 4 |
| Jul 29, 2026 | Halevy GileadDirector | Award | 7,500 | — | Form 4 |
| Jul 29, 2026 | Hukkelhoven MathiasDirector | Award | 7,500 | — | Form 4 |
| Jul 29, 2026 | Livnat Savitzky KinneretDirector | Award | 7,500 | — | Form 4 |
| Jul 29, 2026 | Kredo Russo SharonSVP, Research & Discovery | Award | 18,000 | — | Form 4 |
| Jul 29, 2026 | Perry EranDirector | Award | 7,500 | — | Form 4 |
| Jul 29, 2026 | Silberman DavidChief Financial Officer | Award | 19,500 | — | Form 4 |
| Jul 29, 2026 | Levine ZuritSVP, Business Development | Award | 18,000 | — | Form 4 |
| Jul 9, 2026 | Levine ZuritSVP, Business Development | Sale | 1,875 | $4.69K | Form 4 |
| Jul 9, 2026 | Levine ZuritSVP, Business Development | Option exercise | 1,875 | $1.55K | Form 4 |
| Apr 24, 2026 | Ophir EranPresident and CEO | Sale | 5,000 | $16.00K | Form 4 |
| Apr 24, 2026 | Ophir EranPresident and CEO | Option exercise | 5,000 | $4.15K | Form 4 |
| Apr 24, 2026 | Levine ZuritSVP, Business Development | Sale | 2,000 | $6.40K | Form 4 |
| Apr 24, 2026 | Levine ZuritSVP, Business Development | Option exercise | 2,000 | $2.30K | Form 4 |
| Apr 14, 2026 | Ophir EranPresident and CEO | Sale | 5,000 | $14.52K | Form 4 |
| Apr 14, 2026 | Ophir EranPresident and CEO | Option exercise | 5,000 | $4.15K | Form 4 |
| Apr 14, 2026 | Levine ZuritSVP, Business Development | Sale | 2,000 | $5.60K | Form 4 |
| Apr 14, 2026 | Levine ZuritSVP, Business Development | Option exercise | 2,000 | $2.30K | Form 4 |
| Apr 10, 2026 | Levine ZuritSVP, Business Development | Sale | 3,125 | $8.01K | Form 4 |
| Apr 10, 2026 | Levine ZuritSVP, Business Development | Option exercise | 2,000 | $2.30K | Form 4 |
| Apr 10, 2026 | Levine ZuritSVP, Business Development | Option exercise | 1,125 | $932.85 | Form 4 |
| Apr 10, 2026 | Levine ZuritSVP, Business Development | Sale | 3,125 | $8.01K | Form 4 |
| Apr 10, 2026 | Levine ZuritSVP, Business Development | Option exercise | 2,000 | $2.30K | Form 4 |
| Apr 10, 2026 | Levine ZuritSVP, Business Development | Option exercise | 1,125 | $932.85 | Form 4 |
| Apr 8, 2026 | Levine ZuritSVP, Business Development | Sale | 5,375 | $13.01K | Form 4 |
| Apr 8, 2026 | Levine ZuritSVP, Business Development | Option exercise | 1,000 | $1.15K | Form 4 |
| Apr 8, 2026 | Levine ZuritSVP, Business Development | Option exercise | 4,375 | $3.63K | Form 4 |
| Apr 7, 2026 | Levine ZuritSVP, Business Development | Sale | 2,500 | $5.75K | Form 4 |
| Apr 7, 2026 | Levine ZuritSVP, Business Development | Option exercise | 2,500 | $2.07K | Form 4 |
| Apr 1, 2026 | Ophir EranPresident and CEO | Sale | 5,625 | $12.41K | Form 4 |
| Apr 1, 2026 | Ophir EranPresident and CEO | Option exercise | 5,625 | $4.66K | Form 4 |
| Apr 1, 2026 | Levine ZuritSVP, Business Development | Sale | 3,500 | $7.70K | Form 4 |
| Apr 1, 2026 | Levine ZuritSVP, Business Development | Option exercise | 1,000 | $1.15K | Form 4 |
| Apr 1, 2026 | Levine ZuritSVP, Business Development | Option exercise | 2,500 | $2.07K | Form 4 |
| Mar 26, 2026 | Levine ZuritSVP, Business Development | Sale | 11,875 | $24.19K | Form 4 |
| Mar 26, 2026 | Levine ZuritSVP, Business Development | Option exercise | 11,875 | $9.85K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4